# BBC Presenter Maryam Moshiri Opens Up About Living With Polycythaemia Vera Diagnosis
BBC presenter Maryam Moshiri received a polycythaemia vera (PV) diagnosis in November 2024 after her general practitioner identified abnormalities during routine blood work. Rather than viewing the condition as a death sentence, Moshiri has adopted a perspective focused on managing her chronic illness and continuing her life.
Polycythaemia vera belongs to a category of myeloproliferative neoplasms, rare blood cancers where bone marrow produces too many red blood cells. The excess cells thicken the blood, raising risks for clots, strokes, and heart attacks. The condition typically develops slowly and affects roughly one to three people per million in the United Kingdom.
Moshiri's case highlights how routine screening catches disease early. Her GP recognized the blood test irregularities before symptoms emerged, enabling prompt diagnosis and treatment planning. Early detection often improves outcomes significantly.
The presenter's public disclosure matters. Moshiri's willingness to discuss her diagnosis reduces stigma around cancer diagnoses and chronic illness. Many people assume any cancer diagnosis means terminal illness. Polycythaemia vera, however, can remain stable for years with proper management. Some patients experience a normal lifespan.
Treatment options for polycythaemia vera include phlebotomy, the removal of blood to reduce red cell counts, and medications like hydroxyurea or ruxolitinib. Aspirin helps prevent clots. Patients typically monitor blood work regularly and adjust treatment based on results. The goal centers on reducing complications while maintaining quality of life.
Living with a chronic cancer diagnosis requires psychological adjustment. Patients navigate ongoing medical appointments, medication side effects, and uncertainty about disease progression. Moshiri's public statement that she will not die from this condition reflects either her medical team's assessment or her own determination to frame her experience positively. Both matter for mental health outcomes.
Research shows that patient attitude influences quality of life during chronic illness, though not disease progression itself. Adopting an active role in treatment decisions, maintaining social connections, and setting realistic goals improve psychological wellbeing. Moshiri continues her broadcasting work, suggesting she prioritizes maintaining her professional and personal roles despite diagnosis.
Support systems play a role in managing polycythaemia vera. Patients benefit from hematologists experienced with myeloproliferative neoplasms, as these specialists understand disease variability and treatment nuances. Support groups connect patients facing similar experiences.
Moshiri's case also demonstrates why regular health screening matters. Asymptomatic people often skip appointments. Finding abnormalities during routine blood work, before symptoms develop, allows earlier intervention. Her GP's attention to detail likely improved her long-term health trajectory.
The presenter's openness invites broader conversation about living with illness rather than dying from it. Polycythaemia vera requires lifelong monitoring and treatment, but many people manage the condition for decades. Moshiri's public stance normalizes chronic disease as part of life rather than life's end.